In a report released yesterday, Marie Thibault from BTIG maintained a Hold rating on Venus Concept (VERO – Research Report). The company’s shares closed yesterday at $1.21.
According to TipRanks, Thibault is an analyst with an average return of -0.9% and a 34.72% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Delcath Systems, Masimo, and Accuray.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Venus Concept with a $10.60 average price target.
See Insiders’ Hot Stocks on TipRanks >>
VERO market cap is currently $6.69M and has a P/E ratio of -0.17.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Venus Concept (VERO) Company Description:
Venus Concept, Inc. is a medical aesthetic technology company. Its product portfolio consists of aesthetic device platforms which includes venus versa, venus legacy, venus velocity, venus fiore, venus viva, venus freeze plus, and venus bliss. The company was founded in 2002 and is headquartered in Toronto, Canada.
Read More on VERO:
